BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15127203)

  • 1. Common polymorphisms in the genes regulating the early insulin signalling pathway: effects on weight change and the conversion from impaired glucose tolerance to Type 2 diabetes. The Finnish Diabetes Prevention Study.
    Laukkanen O; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    Diabetologia; 2004 May; 47(5):871-7. PubMed ID: 15127203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The G-250A promoter polymorphism of the hepatic lipase gene predicts the conversion from impaired glucose tolerance to type 2 diabetes mellitus: the Finnish Diabetes Prevention Study.
    Todorova B; Kubaszek A; Pihlajamäki J; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    J Clin Endocrinol Metab; 2004 May; 89(5):2019-23. PubMed ID: 15126514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of the Leu72Met polymorphism of the ghrelin gene with the risk of Type 2 diabetes in subjects with impaired glucose tolerance in the Finnish Diabetes Prevention Study.
    Mager U; Lindi V; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Pulkkinen L; Uusitupa M;
    Diabet Med; 2006 Jun; 23(6):685-9. PubMed ID: 16759313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of single nucleotide polymorphisms in ADRB2, ADRB3, TNF, IL6, IGF1R, LIPC, LEPR, and GHRL with physical activity on the risk of type 2 diabetes mellitus and changes in characteristics of the metabolic syndrome: The Finnish Diabetes Prevention Study.
    Kilpeläinen TO; Lakka TA; Laaksonen DE; Mager U; Salopuro T; Kubaszek A; Todorova B; Laukkanen O; Lindström J; Eriksson JG; Hämäläinen H; Aunola S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Uusitupa M;
    Metabolism; 2008 Mar; 57(3):428-36. PubMed ID: 18249219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study.
    Lindi VI; Uusitupa MI; Lindström J; Louheranta A; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Laakso M; Tuomilehto J;
    Diabetes; 2002 Aug; 51(8):2581-6. PubMed ID: 12145174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Promoter polymorphisms of the TNF-alpha (G-308A) and IL-6 (C-174G) genes predict the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.
    Kubaszek A; Pihlajamäki J; Komarovski V; Lindi V; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    Diabetes; 2003 Jul; 52(7):1872-6. PubMed ID: 12829659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic variation in leptin receptor gene is associated with type 2 diabetes and body weight: The Finnish Diabetes Prevention Study.
    Salopuro T; Pulkkinen L; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Laakso M; Uusitupa M;
    Int J Obes (Lond); 2005 Oct; 29(10):1245-51. PubMed ID: 15997246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymorphisms in the SLC2A2 (GLUT2) gene are associated with the conversion from impaired glucose tolerance to type 2 diabetes: the Finnish Diabetes Prevention Study.
    Laukkanen O; Lindström J; Eriksson J; Valle TT; Hämäläinen H; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    Diabetes; 2005 Jul; 54(7):2256-60. PubMed ID: 15983230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes.
    Kilpeläinen TO; Lakka TA; Laaksonen DE; Laukkanen O; Lindström J; Eriksson JG; Valle TT; Hämäläinen H; Aunola S; Ilanne-Parikka P; Keinänen-Kiukaanniemi S; Tuomilehto J; Uusitupa M; Laakso M;
    Physiol Genomics; 2007 Oct; 31(2):264-72. PubMed ID: 17636114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Variants of transcription factor 7-like 2 (TCF7L2) gene predict conversion to type 2 diabetes in the Finnish Diabetes Prevention Study and are associated with impaired glucose regulation and impaired insulin secretion.
    Wang J; Kuusisto J; Vänttinen M; Kuulasmaa T; Lindström J; Tuomilehto J; Uusitupa M; Laakso M
    Diabetologia; 2007 Jun; 50(6):1192-200. PubMed ID: 17437080
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The G1057D polymorphism of IRS-2 gene and its relationship with obesity in conferring susceptibility to type 2 diabetes in Asian Indians.
    Bodhini D; Radha V; Deepa R; Ghosh S; Majumder PP; Rao MR; Mohan V
    Int J Obes (Lond); 2007 Jan; 31(1):97-102. PubMed ID: 16652127
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study.
    Diabetologia; ; . PubMed ID: 15309292
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.